Jonathan Young is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Dec 2018: Akero Therapeutics, Inc. (South San Francisco, CA — other health care — 2018; $45.5M reported sold to 20 investors).
What this means One deal on file with the SEC, filed Dec 2018. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Aaron Kantoff (1 shared filing), Aaron Royston (1 shared filing), Andrew Cheng (1 shared filing), Graham Walmsley (1 shared filing), Kevin Bitterman (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jonathan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Jonathan Young and found 4 differences: Same name, different state: "Jonathan Peter Young" (Y7) is a separate record; Same name, different state: "Jonathan Young" (MD) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.